Clubhouse-based care for people with schizophrenia and related conditions
Official title: Pilot Study of the Cognitive and Neurobiological Effects of the Clubhouse Model of Psychosocial Rehabilitation for Schizophrenia and Related Conditions
Run by Case Western Reserve University · NCT07006935 · Data updated 2026-11-12
This study tests whether the Clubhouse Model of psychosocial rehabilitation helps thinking skills and daily function more than usual community mental health care in adults with schizophrenia, schizoaffective disorder, or schizophreniform disorders.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Case Western Reserve University Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | September 1, 2026 |
| Main results expected | January 30, 2028 |
| Study ends | January 30, 2029 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT07006935 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-50 with a DSM-5 diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform disorder who are newly enrolling in a Clubhouse and stabilized on their psychiatric medications.
✕Probably not a fit
Individuals not benefiting may include those with significant substance use disorders, recent psychiatric instability, or conditions that limit participation or cognition beyond the study's scope.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares a Clubhouse-model community rehabilitation approach to standard care for adults with schizophrenia spectrum or related disorders. Participants complete six visits over six months, including interviews, cognitive tests, and one MRI brain scan. The study aims to see if the Clubhouse model offers unique benefits for cognition and daily functioning. Procedures are non-invasive and include standardized cognitive assessments and brain imaging, with any risks described per standard MRI protocols. Eligibility focuses on adults 18-50 with stabilized medication and English fluency, excluding those with prior Clubhouse membership or certain comorbidities.
Why it matters
Potential benefit: If successful, participants may experience improvements in thinking skills and daily functioning through Clubhouse-based support.
How similar studies have gone: Prior research in community-based psychosocial rehabilitation has shown cognitive and functional benefits in some settings, but the Clubhouse model’s additive effects require confirmation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * (1) have a DSM-V diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform confirmed by diagnostic assessment and medical record review * (2) between the ages of 18-50 * (3) stabilized on psychotropic medication as indicated by no changes to the primary psychiatric medication in the last month * (4) able to read and speak fluent English at a sixth grade level or higher for purposes of informed consent and cognitive testing * For Clubhouse members, they must be a first-time, newly enrolled member Exclusion Criteria: * (1) had previous membership at a Clubhouse (Magnolia or elsewhere) * (2) have a current severe substance use disorder * (3) have persistent suicidal or homicidal behavior * (4) a co-occurring diagnosis of an intellectual or learning disability or neurodevelopment condition (e.g., Autism; based on chart review) * (5) had recent psychiatric instability requiring hospitalization in the past month; * (6) history of a traumatic brain injury (TBI; based on record review) * (7) contraindicators for MRI (e.g., pacemaker, claustrophobia) * Participants in the usual care will be excluded if they are a current Clubhouse member or join a Clubhouse during participation in this research
Where it's running
-
Case Western Reserve University
Cleveland, Ohio, United States Recruiting
Study contacts
- Principal investigator: Jessica A Wojtalik, PhD — Case Western Reserve University
- Study coordinator: Jessica A Wojtalik, PhD
- Email: reach-study@case.edu
- Phone: 216-368-1329
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using iTBS to Improve Social Cognition in People with Psychosis
This study is testing whether a new brain stimulation treatment can help people with schizophrenia improve their social skills and thinking.
-
Bazedoxifene treatment for women with schizophrenia
This study is testing if adding bazedoxifene to regular antipsychotic medication can help women with schizophrenia feel better and think more clearly.
-
Using Lumateperone to improve motivation in patients with schizophrenia and psychosis
This study is testing if Lumateperone can help people with schizophrenia or schizoaffective disorders feel more motivated and less apathetic.
-
Sodium benzoate added to standard treatment for treatment-resistant schizophrenia
This study tests whether adding sodium benzoate helps people with treatment-resistant schizophrenia see better symptoms and cognition.
-
Effects of lumateperone on metabolic side effects in patients taking clozapine for schizophrenia
This study is testing if adding lumateperone to clozapine treatment can help people with schizophrenia reduce weight gain and cholesterol issues caused by their medication.
-
Virtual reality program to improve cognitive skills in people with psychosis
This study tests whether a virtual reality program can help people with psychosis improve their thinking and social skills over six weeks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.